Results 211 to 220 of about 684,204 (318)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Health systems performance in health outcomes, health financing and COVID-19 pandemic: Lessons from 31 countries. [PDF]

PLoS One
Kolivand P, Arabloo J, Saberian P, Dorooudi T, Rajaie S, Karimi F, Raei B, Behzadifar M, Parvari A, Ehsanzadeh SJ, Homayoun S, Salehbeigi S, Namdar P, Azari S.   +13 more
europepmc   +1 more source

VOLUNTARY HEALTH INSURANCE AS A METHOD OF HEALTH CARE FINANCING IN EUROPEAN COUNTRIES

, 2011
Marta Borda
openalex   +1 more source

Recurrent costs of HIV/AIDS‐related health services in Rwanda: implications for financing [PDF]

, 2008
Wilm Quentin, Hans‐Helmut König, Jean‐Olivier Schmidt, Andreas Kalk   +3 more
openalex   +1 more source

Financing Health Care and the Effect of the Tax Law [PDF]

, 1975
Bromberg, Robert S.
core   +3 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Linking Health Financing to Oral Health Coverage and Disease Burden in SEARO Countries: A Cross-Sectional Analysis of Country Level Data. [PDF]

Int J Health Plann Manage
Acharya S, Mathur MR, Tadakamadla SK, Brand A.   +3 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Gender bias in health financing methods: metrics and data. [PDF]

BMJ Glob Health
Chalkidou K, Sullivan R.
europepmc   +1 more source

An overview of health financing patterns and the way forward in the who african region

, 2007
Joses Muthuri Kirigia, Alex Preker, Guy Carrin, Chris Mwikisa, AJ Diarra-Nama   +4 more
openalex   +2 more sources